Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Technology Trust Regulatory News (PCT)

Share Price Information for Polar Capital Technology Trust (PCT)

Share Price is delayed by 15 minutes
Get Live Data
710.00    -18.50 (-2.54%)
Bid:
708.50
Ask:
709.50
Spread: 1.00 (0.141%)
Market Cap: £7.90b
PCT Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Technology Trust Share Chart

Update from QuotedData

15 Aug 2025 16:12

RNS Number : 5931V
Polar Capital Technology Trust PLC
15 August 2025
 

Polar Capital Technology - Update from QuotedData

14th August 2025

AI of the tiger

Polar Capital Technology's (PCT's) underweight positions in Apple and Alphabet have paid off handsomely in recent months - with the share price of both stalling on fears of their vulnerability in the artificial intelligence (AI) race. This points to the increasingly evident merits of an active approach to investing in AI. History suggests that not only will incumbents fall by the wayside and new entrants emerge as AI innovation explodes, but the sector will experience bouts of volatility, with inevitable bumps along the road. What seems certain is the all-encompassing potential of AI to change the world. In this context, backing a manager with the requisite skillset and experience seems of paramount importance.

In our view, PCT is the premier manager for the job, with one of the largest teams dedicated to the sector in Europe and the conviction of its investment philosophy. As the appeal of PCT's active approach is recognised (having comprehensively outperformed its Dow Jones Global Technology benchmark over the past 12 months), this should manifest in a tighter share price discount to net asset value (NAV)

Full Research:

https://quoteddata.com/research/polar-capital-technology-ai-of-the-tiger-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Polar Capital Technology Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPAMATMTMBBIA
Date   Source Headline
6th Feb 20253:43 pmRNSTop Fifteen Equity Holdings and Exposures
6th Feb 202512:16 pmRNSNet Asset Value(s)
5th Feb 20255:20 pmRNSTransaction in Own Shares
5th Feb 202511:43 amRNSNet Asset Value(s)
4th Feb 20255:56 pmRNSTransaction in Own Shares
4th Feb 202512:12 pmRNSNet Asset Value(s)
3rd Feb 202511:57 amRNSNet Asset Value(s)
3rd Feb 202510:56 amRNSTotal Voting Rights
3rd Feb 20258:30 amRNS-RPolar Capital Technology enters the FTSE 100 Index
31st Jan 20251:48 pmRNSNet Asset Value(s)
30th Jan 20251:00 pmRNSHolding(s) in Company
30th Jan 202512:20 pmRNSNet Asset Value(s)
29th Jan 20256:00 pmRNSSmith (DS)
29th Jan 202511:56 amRNSNet Asset Value(s)
28th Jan 20251:58 pmRNSNet Asset Value(s) - Replacement
28th Jan 202512:46 pmRNSNet Asset Value(s)
27th Jan 202512:07 pmRNSNet Asset Value(s)
24th Jan 202512:34 pmRNSNet Asset Value(s)
23rd Jan 20255:17 pmRNSTransaction in Own Shares
23rd Jan 202511:57 amRNSNet Asset Value(s)
22nd Jan 20255:09 pmRNSTransaction in Own Shares
22nd Jan 20252:09 pmRNSFactsheet
22nd Jan 202512:07 pmRNSNet Asset Value(s)
21st Jan 20255:34 pmRNSTransaction in Own Shares
21st Jan 202511:18 amRNSNet Asset Value(s)
20th Jan 202512:20 pmRNSNet Asset Value(s)
17th Jan 20255:02 pmRNSTransaction in Own Shares
17th Jan 202512:01 pmRNSNet Asset Value(s)
16th Jan 20251:24 pmRNS-RAnnual Overview from QuotedData
16th Jan 202512:11 pmRNSNet Asset Value(s)
15th Jan 20255:12 pmRNSTransaction in Own Shares
15th Jan 202511:52 amRNSNet Asset Value(s)
14th Jan 20255:09 pmRNSTransaction in Own Shares
14th Jan 202511:42 amRNSNet Asset Value(s)
13th Jan 202512:59 pmRNSNet Asset Value(s)
10th Jan 20255:11 pmRNSTransaction in Own Shares
10th Jan 202511:51 amRNSNet Asset Value(s)
9th Jan 202512:07 pmRNSNet Asset Value(s)
8th Jan 20255:22 pmRNSTransaction in Own Shares
8th Jan 202511:42 amRNSNet Asset Value(s)
7th Jan 20255:18 pmRNSTransaction in Own Shares
7th Jan 20254:09 pmRNSTop Fifteen Equity Holdings and Exposures
7th Jan 202512:00 pmRNSNet Asset Value(s)
6th Jan 20255:34 pmRNSTransaction in Own Shares
6th Jan 202511:48 amRNSNet Asset Value(s)
3rd Jan 20255:05 pmRNSTransaction in Own Shares
3rd Jan 202512:13 pmRNSNet Asset Value(s)
2nd Jan 20255:06 pmRNSTransaction in Own Shares
2nd Jan 20253:20 pmRNSBlock listing Interim Review
2nd Jan 20251:21 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.